$0.70
3.18% day before yesterday
Nasdaq, Dec 26, 10:00 pm CET

Harvard Bioscience, Inc. Stock price

$0.70
-0.05 6.29% 1M
+0.19 37.19% 6M
-1.41 66.72% YTD
-1.40 66.56% 1Y
-2.03 74.27% 3Y
-3.62 83.74% 5Y
-2.96 80.81% 10Y
-2.65 79.03% 20Y
Nasdaq, Closing price Fri, Dec 26 2025
-0.02 3.18%

Key metrics

Basic
Market capitalization
$31.3m
Enterprise Value
$58.5m
Net debt
$27.2m
Cash
$6.8m
Shares outstanding
44.6m
Valuation (TTM | estimate)
P/E
negative | 23.0
P/S
0.4 | 0.4
EV/Sales
0.7 | 0.7
EV/FCF
8.6
P/B
2.2
Financial Health
Equity Ratio
50.0%
Return on Equity
-19.6%
ROCE
-8.2%
ROIC
-3.2%
Debt/Equity
2.4
Financials (TTM | estimate)
Revenue
$87.4m | $87.6m
EBITDA
$2.5m | $8.1m
EBIT
$-1.9m | $-50.2m
Net Income
$-53.8m | $1.4m
Free Cash Flow
$6.8m
Growth (TTM | estimate)
Revenue
-10.6% | -6.9%
EBITDA
12,350.0% | 6,815.0%
EBIT
63.8% | -832.8%
Net Income
-278.1% | 111.0%
Free Cash Flow
4,162.5%
Margin (TTM | estimate)
Gross
56.9%
EBITDA
2.9% | 9.2%
EBIT
-2.2%
Net
-61.6% | 1.6%
Free Cash Flow
7.8%
More
EPS
$-1.2
FCF per Share
$0.2
Short interest
1.4%
Employees
343
Rev per Employee
$270.0k
Show more

Is Harvard Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Harvard Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Harvard Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
87 87
11% 11%
100%
- Direct Costs 38 38
7% 7%
43%
50 50
13% 13%
57%
- Selling and Administrative Expenses 38 38
16% 16%
43%
- Research and Development Expense 8.97 8.97
20% 20%
10%
2.49 2.49
12,350% 12,350%
3%
- Depreciation and Amortization 4.43 4.43
18% 18%
5%
EBIT (Operating Income) EBIT -1.94 -1.94
64% 64%
-2%
Net Profit -54 -54
278% 278%
-62%

In millions USD.

Don't miss a Thing! We will send you all news about Harvard Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Harvard Bioscience, Inc. Stock News

Neutral
GlobeNewsWire
10 days ago
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities  HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced it entered...
Negative
CNBC
about one month ago
Former Treasury Secretary Larry Summers said he was stepping back from all public commitments amid fallout from the release of emails between him and sex offender Jeffrey Epstein. "I am deeply ashamed of my actions and recognize the pain they have caused.
Neutral
Seeking Alpha
about 2 months ago
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants John Duke - President, CEO & Director Mark Frost - Interim CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Taylor Krafchik Lucas Baranowski - KeyBanc Capital Markets Inc., Research Division Bruce Jackson - The Benchmark Company, LLC, R...
More Harvard Bioscience, Inc. News

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Head office United States
CEO James Green
Employees 343
Founded 1901
Website www.harvardbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today